Consensus in the Management of Multiple Myeloma in India at Myeloma State of the Art 2016 Conference

被引：13
|
作者：
Yanamandra, Uday [1 ]
Khattry, Navin [2 ]
Kumar, Shaji [3 ]
Raje, Noopur [4 ]
Jain, Arihant [1 ]
Jagannath, Sundar [5 ]
Menon, Hari [6 ]
Kumar, Lalit [7 ]
Varma, Neelam [1 ]
Varma, Subhash [1 ]
Saikia, Tapan [8 ]
Malhotra, Pankaj [1 ]
机构：
[1] PGIMER, Dept Internal Med, Chandigarh 160012, India
[2] Tata Mem Hosp, Dept Med Oncol, Bombay, Maharashtra, India
[3] Mayo Clin, Rochester, MN USA
[4] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[5] Tisch Canc Inst, New York, NY USA
[6] Cytecare Hosp, Bengaluru, India
[7] AIIMS, Dept Med Oncol, New Delhi, India
[8] Prince Aly Khan Hosp, Bombay, Maharashtra, India
来源：
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION | 2017年 / 33卷 / 01期
关键词：
Multiple myeloma; Consensus; Indian scenario; Plasma cell dyscrasia; STEM-CELL TRANSPLANTATION; DIAGNOSIS; THERAPY;
D O I：
10.1007/s12288-016-0773-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The science of multiple myeloma (MM) and related plasma cell disorders is rapidly evolving with increased understanding of the disease biology and recent approval of the newer drugs widening the therapeutic armamentarium. Despite multiple international guidelines regarding the management of this disease, the practice of managing MM is not uniform amongst Indian physicians. There are challenges in management which are unique to the Indian patients. This review discusses these challenges and the consensus of the nation-wide experts in dealing with the same. We also briefly highlighted the perspective of international experts as discussed in the Myeloma State of the Art conference held in September 2016 at PGI, Chandigarh. An Indian Myeloma Academic Groupe (IMAGe) group was formed to strengthen the research, create awareness about myeloma and related disorders and form consensus guidelines/recommendations that can be adapted to the Indian Scenario.
引用
收藏
页码：15 / 21
页数：7
相关论文
共 50 条
  • [1] Consensus in the Management of Multiple Myeloma in India at Myeloma State of the Art 2016 Conference
    Uday Yanamandra
    Navin Khattry
    Shaji Kumar
    Noopur Raje
    Arihant Jain
    Sundar Jagannath
    Hari Menon
    Lalit Kumar
    Neelam Varma
    Subhash Varma
    Tapan Saikia
    Pankaj Malhotra
    Indian Journal of Hematology and Blood Transfusion, 2017, 33 : 15 - 21
  • [2] Management of multiple myeloma in Hungary in 2016
    Varga Gergely
    Mikala Gabor
    Varoczy Laszlo
    Illes Arpad
    ORVOSI HETILAP, 2016, 157 (04) : 123 - 137
  • [3] The Singapore Myeloma Study Group Consensus Guidelines for the management of patients with multiple myeloma
    de Mel, Sanjay
    Chen, Yunxin
    Gopalakrishnan, Sathish Kumar
    Ooi, Melissa
    Teo, Constance
    Tan, Daryl
    Teo, Min Li Claire
    Tso, Allison C. Y.
    Lee, Lian King
    Nagarajan, Chandramouli
    Goh, Yeow Tee
    Chng, Wee Joo
    SINGAPORE MEDICAL JOURNAL, 2017, 58 (02) : 55 - 71
  • [4] Clinical management of myeloma - state of the art
    Harousseau, Jean-Luc
    CANCER TREATMENT REVIEWS, 2010, 36 : S1 - S2
  • [5] State of the art treatment of progressive or refractory multiple myeloma
    Schmidt-Wolf, I. G. H.
    Straka, C.
    Scheid, C.
    Einsele, H.
    Goldschmidt, H.
    Engelhardt, M.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 (41) : 2091 - 2095
  • [6] Management of Multiple Myeloma and Usage of Bortezomib: Perspective from india and Ukraine
    Garg, Amit
    Morgunskyy, Mykhaylo
    Belagali, Yogesh
    Gupta, Namita
    Akku, Shyam Prasad
    FRONTIERS IN ONCOLOGY, 2016, 6
  • [7] Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network
    Ludwig, Heinz
    Delforge, Michel
    Facon, Thierry
    Einsele, Hermann
    Gay, Francesca
    Moreau, Philippe
    Avet-Loiseau, Herve
    Boccadoro, Mario
    Hajek, Roman
    Mohty, Mohamad
    Cavo, Michele
    Dimopoulos, Meletios A.
    San-Miguel, Jesus F.
    Terpos, Evangelos
    Zweegman, Sonja
    Garderet, Laurent
    Mateos, Maria-Victoria
    Cook, Gordon
    Leleu, Xavier
    Goldschmidt, Hartmut
    Jackson, Graham
    Kaiser, Martin
    Weisel, Katja
    van de Donk, Niels W. C. J.
    Waage, Anders
    Beksac, Meral
    Mellqvist, Ulf H.
    Engelhardt, Monika
    Caers, Jo
    Driessen, Christoph
    Blade, Joan
    Sonneveld, Pieter
    LEUKEMIA, 2018, 32 (07) : 1542 - 1560
  • [8] Minimal Residual Disease in Multiple Myeloma: State of the Art and Future Perspectives
    Mina, Roberto
    Oliva, Stefania
    Boccadoro, Mario
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 16
  • [9] Proteasome inhibition in combination with immunotherapies: State-of-the-Art in multiple myeloma
    Kegyes, David
    Gulei, Diana
    Drula, Rares
    Cenariu, Diana
    Tigu, Bogdan
    Dima, Delia
    Tanase, Alina
    Badelita, Sorina
    Buzoianu, Anca-Dana
    Ciurea, Stefan
    Ghiaur, Gabriel
    Terpos, Evangelos
    Ciechanover, Aaron
    Einsele, Hermann
    Tomuleasa, Ciprian
    BLOOD REVIEWS, 2023, 61
  • [10] Pain management in multiple myeloma
    Niscola, Pasquale
    Scaramucci, Laura
    Romani, Claudio
    Giovannini, Marco
    Tendas, Andrea
    Brunetti, Gregorio
    Cartoni, Claudio
    Palumbo, Roberto
    Vischini, Gisella
    Siniscalchi, Agostina
    de Fabritiis, Paolo
    Caravita, Tommaso
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (03) : 415 - 425
12345